Endoscopic management of gastroesophageal reflux disease in 2012: What works and what doesn′t

Abstract

Gastroesophageal reflux disease results primarily from the loss of an effective antireflux barrier, which forms a mechanical barrier against the retrograde movement of gastric contents. Multiple devices have been developed for the endoscopic treatment of GERD, using approaches such as sewing, transmural fasteners, endoscopic staplers, and thermal treatment. Devices that are currently commercially available for the endoscopic treatment of GERD in the US include: EndoCinch; EsophyX; Stretta. This article will highlight the endoscopic therapy of gastroesophageal reflux disease with focus on Stretta and EsophyX.

Key words

Endoluminal radiofrequency ablative technology - gastroesophageal reflux disease - fundoplication - stretta procedure

• References

• 1 Triadafilopoulos G, Dibaise JK, Nostrant TT, Stollman NH, Anderson PK, Edmundowicz SA, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc 2001;53:407-15.
• 2 Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: A randomized, sham-controlled trial. Gastroenterology 2003;125:668-75.
• 3 Aziz AM, El-Khayat HR, Sadek A, Mattar SG, McNulty G, Kongkam P, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc 2010;24:818-25.
• 4 Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, Anderson PK, Wolfe MM, et al. Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc 2002;55:149-56.
• 5 Richards WO, Houston HL, Torquati A, Khaitan L, Holzman MD, Sharp KW. Paradigm shift in the management of gastroesophageal reflux disease. Ann Surg 2003;237:638-47.
• 6 White B, Jeansonne LO, Cook M, Chavarriaga LF, Goldenberg EA, Davis SS, et al. Use of endoluminal antireflux therapies for obese patients with GERD. Obes Surg 2009;19:783-7.
• 7 Bell RC, Cadière GB. Transoral rotational esophagogastric fundoplication: Technical, anatomical, and safety considerations. Surg Endosc 2011;25:2387-99.
• 8 Hoppo T, McMahon BP, Witteman BP, Kraemer SJ, O’Rourke RW, Gravesen F, et al. Functional lumen imaging probe to assess geometric changes in the esophagogastric junction following endolumenal fundoplication. J Gastrointest Surg 2011;15:1112-20.
• 9 Testoni PA, Vailati C, Testoni S, Corsetti M. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: Long-term results and findings affecting outcome. Surg Endosc 2011 Dec 15. [Epub ahead of print].
• 10 Nguyen A, Vo T, Nguyen XM, Smith BR, Reavis KM. Transoral incisionless fundoplication: Initial experience in patients referred to an integrated academic institution. Am Surg 2011;77:1386-9
• 11 Narsule CK, Burch MA, Ebright MI, Hess DT, Rivas R Jr, Daly BD, et al. Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: Initial experience. J Thorac Cardiovasc Surg 2012;143:228-34.
• 12 Ihde GM, Besancon K, Deljkich E. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg 2011;202:740-6.
• 13 Frazzoni M, Conigliaro R, Manta R, Melotti G. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 2011;34:67-75.
• 14 Jafri SM, Arora G, Triadafilopoulos G. What is left of the endoscopic antireflux devices? Curr Opin Gastroenterol 2009;25:352-7.